ArticleCancers2026

Real-World Comparison of PD-1 and PD-L1 Inhibitor Monotherapy in Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression.

Filip Marković et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.